Advertisement
Screener

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

1.8 / 5 stars · 14/40 Roast Me

Add as a preferred source on Google

SCINAI IMMUNOTHERAPEUTICS LTD. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $13.70 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2023-04-17

  • SCINAI IMMUNOTHERAPEUTICS LTD. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was $13.70.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month
2022-12-31$13.70
10-K · filed 2023-04-17
Advertisement